Resources
BNET Resources
- sort by:
- Relevance
- Date
- Popularity
- Academic Drug Conflicts Probe: "Problems With Transparency Are Everywhere"
- Emory. Harvard. Stanford. Brown. The University of Texas. The University of Cincinnati. It's a roll call of the nation's most prominent schools of psychiatry. But top researchers and professors at those schools could, essentially, be rented out by drug companies for hundreds of thousands of dollars. Then, those academics allegedly...
- Blog posts 2008-10-03
- Insomnia and Antidepressant Sales Give Lie to DTC Myths
- Direct-to-consumer drug advertising has almost no relationship with consumer demand for prescriptions. That is one interpretation of a story in Ad Age showing that scrips for insomnia pills (such as Sanofi-Aventis's Ambien CR) and antidepressants (such as Eli Lilly's Cymbalta) are up, even though advertising in both those categories is...
- Blog posts 2009-03-05
- Tafas v. Doll: Drug Companies Face New Limits on Patents
- Drug companies will be dismayed by a federal appeals court ruling that came down on Friday which gives the U.S. Patent and Trademark Office new powers to limit the way patents are filed. The drug business depends heavily on its ability to patent chemicals and processes for...
- Blog posts 2009-03-23
- How Drug Advertising Restrictions Could Benefit the Industry
- The drug business spends $5 billion a year on advertising and yet studies continue to emerge suggesting that hundreds of millions of those dollars are wasted. Perhaps it's time to consider whether more restrictions on drug ads might, counterintutively, benefit the industry. ...
- Blog posts 2009-11-05
Additional Resources
- Q&A: How the Drug Business May Lose the Right to Advertise
- With a new president and a Democrat-controlled Congress, lobbyists are already contemplating a scenario in which the drug business either loses or gives up the right to advertise its products to consumers. Such a move would be dramatic, ending a brief, wild decade of animated toenail fungus monsters and warnings...
- Blog posts 2008-11-10
- Bristol-Myers Squibb Announces Focus on Main Drug Business.(Knight Ridder/Tribune Business News)
- Sep. 29--Bristol-Myers Squibb said it will divest its Clairol beauty care business and Zimmer medical products unit and focus more on its main drug business in a bid to push profit growth from the current 11 percent level to the high teens by 2003. ...
- Research articles 2000-09-29
- Bristol-Myers Squibb Buys DuPont Prescription Drug Business.
- By Lewis Krauskopf, The Record, Hackensack, N.J. Knight Ridder/Tribune Business News Jun. 8--Bristol-Myers Squibb Co. struck a $7.8 billion deal Thursday to buy the prescription drug business of chemical giant Du Pont -- a deal that boosts Bristol-Myers' AIDS and cardiovascular ...
- Research articles 2001-06-08
- NitroMed Announces Agreement to Sell BiDil® Drug Business to JHP Pharmaceuticals, LLC
- -- NTMD Reports Financial Results for Third Fiscal Quarter 2008 -- -- Conference Call and Webcast to be Held Today at 10:00 AM ET-- LEXINGTON, Mass. -- NitroMed, Inc. (NASDAQ:NTMD) today announced that JHP Pharmaceuticals, LLC, a privately held specialty pharmaceutical company, has agreed to acquire substantially all...
- Research articles 2008-10-23
- Swinging The Ax At The Drug Companies - The Atlantic Business Channel
- « The Senate Plan's Resolution Authority | Main | Does Excess Debt Lead to Bubbles? » Nov 11 2009, 11:15 am by Derek Lowe Swinging The Ax At The Drug Companies...
- News items 2009-11-12
- The 10 Weirdest Drug Stories of the Month
- Another page has been torn off the calendar, and that means it's time to open up Big Pharma's vault of peculiarities and do a roundup of strange-but-true tales from the world of drugs that surfaced on my radar last month. I give you the 10 weirdest drug...
- Blog posts 2008-10-01
- BMS Wins Ruling That Could Crimp India's Thriving Generics Business
- Bristol-Myers Squibbb just won a ruling in an Indian court that could put generic makers there on the defensive. For years, the Indian drug business has grown primarily from making generics. Companies like Dr. Reddy's, Ranbaxy, Cilpa and Hetero Drugs have chosen to copy compounds marketed in the West rather...
- Blog posts 2009-01-16
- Warner Chilcott reported in $3bn deal for P&G drug unit
- NEW YORK - Warner Chilcott, a specialty drug maker, is acquiring Procter & Gamble's prescription drug business for about $3bn, the Wall Street Journal said on Sunday, citing unnamed sources. A transaction may be announced as soon as Monday, the newspaper said. The business has about $2bn of annual sales,...
- News items 2009-08-23
- Counsel's Choice Drug Business Signs Definitive Agreement To Acquire Premier Pharmacy, Inc
- TORONTO, Ontario--BUSINESS WIRE--APRIL 7, 1995--COUNSEL CORPORATION(TSE: CXS) Allan Silber, Chairman and CEO of Counsel Corporation (TSE-CXS), today announced that the Company's 25%-owned Choice Drug Systems, Inc. (NASDAQ-DOSE) has executed a revised definitive agreement to acquire PremierPharmacy, Inc. Under the revised terms, Choice Drug will acquire PremierPharmacy for U.S. $4,250,000 cash,...
- Research articles 1995-04-07
- Long Rx drug romances end for two major conglomerates
- Long Rx drug romances end for two major conglomerates Two giant chemical companies are divesting their prescription drug subsidiaries, thereby ending long-sought efforts at making it in the prescription drug business. DuPont said it intends to and BASF said it has obtained buyers for its drug units. Abbott...
- Research articles 2001-01-01
- Chugai Pharmaceutical to sell over-counter drug division to Lion Corp.
- Kyodo News International, Tokyo Knight Ridder/Tribune Business News Jul. 30--TOKYO -- Chugai Pharmaceutical Co. said Friday it has agreed to sell its over-the-counter drug operations to health and beauty products maker Lion Corp. by the end of the year to marshal resources...
- Research articles 2004-07-30
- Walgreen warms to mail-order; Drug chain joining trend it's fighting.(News)
- Byline: SANDRA JONES Walgreen Co., the nation's largest drugstore chain, is angling for a bigger slice of the surging mail-order prescription drug business, even as it tries to blunt mail order's growth with hard-line tactics. The Deerfield-bas Byline: SANDRA JONES...
- Research articles 2005-02-21
- Shares soar when FDA gives nod on new drug.(Business)
- Byline: Anna Marie Kukec Daily Herald Business Writer Shares of Schaumburg-based American Pharmaceutical Partners Inc. soared about 14 percent Friday around the time it won government approval to sell a new breast cancer drug called Abraxane. Analysts have speculated for some time...
- Research articles 2005-01-08
- No small plans: upstart eyes drug firm goliaths. (Morton Grove Pharmaceuticals Inc.)(Company Profile)
- Brian Tambi and his small drug company, Morton Grove Pharmaceuticals Inc., won't be threatening behemoths like Eli Lilly & Co. or Abbott Laboratories anytime soon. But in five years, he expects the company to be a heavy hitter. Mr. Tambi's entree to the big leagues: a...
- Research articles 1996-05-20
- Cuti makes mark on NY drug chain
- The retailer's sales in fiscal 1996 increased by some 13%, to a record $380 million, while same-store sales advanced by 7% for the year. More impressive, Duane Read's same-store prescription drug business registered an increase of over 25%, the biggest gain in the chain drug industry. Then too, after experiencing...
- Research articles 1997-03-17
- Grocery Chain Albertson's Buys Omaha, Neb., Pharmaceutical Business.
- Knight Ridder/Tribune Business News Jun. 11--Beaton Drug Co. has closed its three Omaha stores and sold its pharmaceutical business to Albertson's Inc. Albertson's, one of the leading grocery-store chains in the Omaha area, will integrate Beaton's drug business into its own pharmacy operation, said Division...
- Research articles 1998-06-10
- << Previous
- page 1 of 1
- Next >>
